Bank Ganesha Tbk vs Cipta Sarana Medika Tbk. — how do they compare? Bank Ganesha Tbk trades at Rp110 (market cap 2.59T, 543.6K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B, 12.18M 24h volume). The key difference: Bank Ganesha Tbk is far larger — about 16.1× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (12.18M versus 543.6K). Which is the better fit depends on your goals.
| BGTG | DKHH | |
|---|---|---|
Market Cap | 2.59T | 160.67B |
Volume | 543.6K | 12.18M |
Lot | 5.44K | 121.83K |
Turnover | 59.52M | 762.52M |
Average Price | 109.49 | 62.59 |
Value | 59.52M | 762.52M |
Indicative Equilibrium Price | 110 | 63 |
Indicative Equilibrium Volume | 87 | 2.19K |
Trailing returns across standard periods
Latest headlines on both assets
P.T. Bank Ganesha Tbk (”the Bank”) was established based on Deed No. 47 dated May 15, 1990 of notary Esther Daniar Iskandar S.H. The Bank started commercial operations on April 30, 1992 when it obtained its business license based on the Decision Letter No. 393/KMK-013/1992 dated April 14, 1992 from the Minister of Finance of the Republic of Indonesia. In accordance with Bank Indonesia’sDecision Letter No. 26/66/KEP/DIR dated September 12, 1995, the Bank is authorized to be a foreign exchange bank.
Read more on BGTG →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →